Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-102 Dose-Ranging Study for Abdominal Fat Reduction
NCT00918814Phase 2Completed
- Sponsor
- Neothetics
- Start
- Jun 2009
- Primary completion
- Feb 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, fluticasone propionate in localized adiposity (AL), sponsored by Neothetics. Started Jun 2009; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on NCT00918814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918814.